News

(©Angellodeco, AdobeStock.com)

In a recent edition of Frontiers in Immunology, Dr. Walter Maksymowych, University of Alberta, reviews the use of biomarkers for diagnosis and prognosis in axial spondyloarthritis. Learn more in this summary.

(©PhotographE,Shutterstock.com).jpg

A review article confirms low adherence and persistence rates for medication compliance in rheumatoid arthritis, psoriasis and psoriatic arthritis. Patients with higher adherence rates had better outcomes.

(©Kirhan, AdobeStock).jpeg

African American women are disproportionately likely to develop systemic lupus erythematosus, and their disease course is more severe than other demographic groups, says Dr. Edith Williams. In this Q&A, she introduces us to a peer-mentoring program designed to foster self-management.

(©Balsamic, AdobeStock)

Patient-doctor narrative matters, says Lisa Rosenbaum, M.D., a cardiologist with Brigham and Women's Hospital in Boston. She shared her insights on patient narratives last month at LUPUS 2019 in San Francisco where she gave the keynote address. Learn more in this Q&A. 

 (©Photographee.eu, AdobeStock.com)

Rheumatoid arthritis patients taking tofacitinib could face some increased risks for significant cardiovascular events, depending upon their underlying characteristics, according to the results of a new study.

(©Kikkerdirk, AdobeStock)

OARSI 2019: Phase IIIb clinical trial for the extended release injectable triamcinolone acetonide (Zilretta, Flexion) shows improvement in pain, stiffness and function. 

(©Philip Steury, AdobeStock)

OARSI 2019:  Men and women with a mother or sibling who have osteoarthritis, have an increased risk of osteoarthritis in the hips, knees and hands.